Protalix BioTherapeutics Reports Third Quarter 2019 Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. BAC

Go back to Protalix BioTherapeutics Reports Third Quarter 2019 Results and Provides Corporate Update

Protalix BioTherapeutics (PLX) Misses Q3 EPS by 10c

November 7, 2019 6:53 AM EST

Protalix BioTherapeutics (NYSE: PLX) reported Q3 EPS of ($0.13), $0.10 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $12.09 million versus the consensus estimate of $11.6 million.

"This has been a consequential quarter for Protalix during which we continued... More